Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

64.86
-1.0500-1.59%
Volume:122.64K
Turnover:7.88M
Market Cap:2.75B
PE:-32.55
High:66.58
Open:66.58
Low:63.37
Close:65.91
52wk High:85.25
52wk Low:38.51
Shares:42.45M
Float Shares:30.35M
Volume Ratio:0.34
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9925
EPS(LYR):-3.0729
ROE:-28.35%
ROA:-12.00%
PB:8.22
PE(LYR):-21.11

Loading ...

Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Sep 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report